Jpmorgan Chase & CO Day One Biopharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 60,453 shares of DAWN stock, worth $895,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,453

Previous 71,209 15.1%

Holding current value

$895,308

Previous $1.18 Million 29.17%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$12.03 - $17.69 $129,394 - $190,273	-10,756 Reduced 15.1%	60,453 $833,000
Q1 2024 May 10, 2024	SELL	$13.56 - $17.46 $455,439 - $586,429	-33,587 Reduced 32.05%	71,209 $1.18 Million
Q4 2023 Feb 12, 2024	BUY	$9.68 - $15.37 $128,453 - $203,959	13,270 Added 14.5%	104,796 $1.53 Million
Q3 2023 Nov 14, 2023	BUY	$11.22 - $14.86 $268,629 - $355,778	23,942 Added 35.43%	91,526 $1.12 Million
Q2 2023 Aug 11, 2023	BUY	$11.74 - $14.47 $532,679 - $656,547	45,373 Added 204.28%	67,584 $806,000
Q1 2023 May 18, 2023	BUY	$12.75 - $23.41 $270,440 - $496,549	21,211 Added 2121.1%	22,211 $296,000
Q1 2023 May 11, 2023	SELL	$12.75 - $23.41 $905,326 - $1.66 Million	-71,006 Reduced 98.61%	1,000 $13,000
Q4 2022 Feb 13, 2023	SELL	$18.77 - $22.0 $99,631 - $116,776	-5,308 Reduced 6.87%	72,006 $1.55 Million
Q3 2022 Nov 14, 2022	BUY	$16.44 - $26.57 $999,535 - $1.62 Million	60,799 Added 368.14%	77,314 $1.55 Million
Q2 2022 Aug 11, 2022	SELL	$5.72 - $17.9 $25,373 - $79,404	-4,436 Reduced 21.17%	16,515 $295,000
Q1 2022 May 11, 2022	SELL	$9.12 - $17.47 $282,802 - $541,727	-31,009 Reduced 59.68%	20,951 $208,000
Q4 2021 Feb 10, 2022	BUY	$15.65 - $26.33 $747,084 - $1.26 Million	47,737 Added 1130.4%	51,960 $875,000
Q3 2021 Nov 12, 2021	BUY	$20.0 - $27.92 $84,460 - $117,906	4,223 New	4,223 $100,000

Others Institutions Holding DAWN

# of Institutions

167

Shares Held

72M

Call Options Held

163K

Put Options Held

183K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $1.09B
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Day One Biopharmaceuticals, Inc. Transaction History